It has been suggested that a mutated ETFDH gene leads to secondary CoQ10 deficiency and patients have shown beneficial long-term responses to CoQ10 and riboflavin supplementation [18]. The gene discussed is ETFDH; the disease is coenzyme Q10 deficiency.